Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.
News about AMETEK, Inc. (NYSE: AME) centers on its role as a global provider of industrial technology solutions and its financial and strategic developments. Corporate profile statements in earnings and dividend releases describe AMETEK as serving a diverse set of attractive niche markets with annual or annualized sales in the multi-billion-dollar range, supported by its Electronic Instruments Group and Electromechanical Group.
Investors following AME news will see regular quarterly earnings announcements, where AMETEK reports record sales, operating income, segment performance, and non-GAAP measures such as adjusted operating income and adjusted diluted earnings per share. These releases often include outlook commentary and updated full-year guidance, along with details by segment for the Electronic Instruments Group and the Electromechanical Group.
AMETEK news also features capital allocation and shareholder return updates, including Board-approved quarterly dividend declarations that specify dividend amounts, record dates, and payment dates. The company’s emphasis on cash generation and disciplined capital deployment is a recurring theme in these communications.
Another important category of AME news involves strategic acquisitions and portfolio developments. For example, AMETEK announced the completion of its acquisition of FARO Technologies, describing FARO as a provider of 3D measurement and imaging solutions that joins AMETEK’s Ultra Precision Technologies Division within the Electronic Instruments Group. News from AMETEK-affiliated businesses, such as SkyBitz, highlights new product launches in areas like real-time tank monitoring and illustrates how AMETEK’s business units serve industries including gas, water, chemical, and petroleum.
Visitors to this AME news page can review these earnings releases, dividend announcements, acquisition updates, and product-related news to understand how AMETEK applies its growth model of Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions over time.
AMETEK (NYSE: AME) appointed Nick L. Stanage to its Board of Directors effective May 8, 2026.
Stanage is former chairman and CEO of Hexcel (NYSE: HXL), retired May 2024, and currently serves on the boards of Hexcel, Huntington Ingalls Industries, and TriMas. AMETEK reports ~$7.5 billion in annual sales.
AMETEK (NYSE: AME) declared a regular quarterly dividend of $0.34 per share for the quarter ending June 30, 2026. The dividend is payable on June 30, 2026 to shareholders of record as of June 15, 2026.
AMETEK reports approximately $7.5 billion in annual sales and reiterates its Growth Model focused on operational excellence, technology innovation, global expansion, and strategic acquisitions.
AMETEK (NYSE: AME) agreed to acquire Indicor Instrumentation in an all-cash transaction valued at approximately $5.0 billion, expected to close in the second half of 2026 subject to regulatory approvals.
Indicor generates about $1.1 billion in annual sales and will be integrated into AMETEK's Electronic Instruments Group and Electromechanical Group. AMETEK plans to fund the deal with borrowings under its credit facility and new debt issuance.
AMETEK (NYSE: AME) announced an agreement to acquire First Aviation Services, a defense and aviation MRO provider with annual sales of approximately $80 million and six U.S. centers of excellence. The deal expands AMETEK's component MRO capabilities across electronics, rotor blades, propellers, landing gear and flight controls. The transaction is subject to customary closing conditions, including regulatory approvals.
AMETEK reported annual sales of about $7.5 billion and reiterated its Growth Model focused on operational excellence, technology innovation, global expansion and strategic acquisitions.
AMETEK (NYSE: AME) reported record Q1 2026 results: sales $1.93 billion (+11% YoY), GAAP EPS $1.74, and adjusted EPS $1.97 (+13% YoY). GAAP operating income was $514.9 million; adjusted operating income was $516.6 million and margins rose to 26.8% (+50 bps). Orders grew 23%, producing a record backlog. Management raised 2026 adjusted EPS guidance to $7.94–$8.14 and expects full-year sales up high single digits. AMETEK highlighted strong organic growth, acquisition contributions, and cash-generative operations.
AMETEK (NYSE: AME) will release first quarter 2026 earnings before the market opens on Thursday, April 30, 2026 and will host a live investor conference call the same day at 8:30 AM ET. The live audio webcast and replay will be available via the Investors > Events & Presentations section of www.ametek.com.
Corporate profile: AMETEK reported annual sales of approximately $7.5 billion, aims for double‑digit EPS growth over the business cycle, pursues four growth strategies, and is a component of the S&P 500.
AMETEK (NYSE: AME) announced a 10% increase in its quarterly cash dividend to $0.34 per share from $0.31. The first-quarter dividend is payable March 31, 2026 to holders of record on March 16, 2026, raising the indicated annual rate to $1.36 per share.
Management cited strong growth, cash flow generation and a solid financial position, and reaffirmed a commitment to strategic acquisitions alongside returning cash to shareholders. Company annual sales are about $7.5 billion.
DW Healthcare Partners announced the sale of LKC Technologies to AMETEK (NYSE: AME) on Feb. 3, 2026. LKC, a portfolio company of DWHP's Founders Fund, develops the handheld, non-invasive RETeval electroretinography (ERG) device to support retinal and optic nerve disease diagnosis. William Blair was exclusive financial advisor to LKC.
The announcement highlights LKC's 35+ years of diagnostic innovation and DWHP's three-year partnership to scale operations and raise awareness of functional retinal testing.
AMETEK (NYSE: AME) announced on February 3, 2026 the acquisition of LKC Technologies, a provider of portable diagnostic devices for ophthalmic conditions, joining AMETEK's Electronic Instruments Group (EIG).
The deal expands AMETEK's ophthalmic product portfolio, aligns LKC with the Ultra Precision Technologies Reichert business, and supports market expansion in eye‑care diagnostics. AMETEK reported annual sales of approximately $7.5 billion and reaffirmed its growth model emphasizing strategic acquisitions and double‑digit EPS growth over the cycle.
AMETEK (NYSE: AME) reported record fourth-quarter and full‑year 2025 results on Feb 3, 2026. Q4 sales were $2.0 billion, +13% YoY, GAAP EPS was $1.73 and adjusted EPS was a record $2.01. Q4 adjusted operating income was $523.0 million.
For full year 2025, sales were $7.4 billion (+7% YoY), GAAP EPS $6.40, adjusted EPS $7.43 (+9% YoY). Free cash flow and several operating metrics set annual records. 2026 guidance: sales up mid‑to‑high single digits; adjusted EPS $7.87–$8.07.